Forte Biosciences, Inc. (FBRX)
NASDAQ: FBRX · Real-Time Price · USD
20.92
-0.40 (-1.88%)
At close: Jul 2, 2026, 4:00 PM EDT
20.00
-0.92 (-4.40%)
After-hours: Jul 2, 2026, 6:35 PM EDT
Forte Biosciences Market Cap
Forte Biosciences has a market cap or net worth of $511.19 million as of July 2, 2026. Its market cap has increased by 527.21% in one year.
Market Cap
511.19M
Enterprise Value
452.97M
1-Year Change
527.21%
Ranking
Category
Stock Price
$20.92
Market Cap Chart
Since June 16, 2020, Forte Biosciences's market cap has increased from $181.43M to $511.19M, an increase of 181.75%. That is a compound annual growth rate of 18.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2026 | 511.19M | 5.13% |
| Dec 31, 2025 | 486.26M | 234.91% |
| Dec 31, 2024 | 145.19M | 386.30% |
| Dec 29, 2023 | 29.86M | 42.17% |
| Dec 30, 2022 | 21.00M | -33.49% |
| Dec 31, 2021 | 31.57M | -93.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neurogene | 535.37M |
| XOMA Royalty | 534.50M |
| Arvinas | 529.07M |
| Assembly Biosciences | 528.92M |
| Nuvectis Pharma | 517.78M |
| Rezolute | 517.11M |
| Kyverna Therapeutics | 513.11M |
| Editas Medicine | 503.35M |